Neha Kumar, MD | |
833 S Governors Ave, Dover, DE 19904-4158 | |
(800) 900-2020 | |
(302) 269-3503 |
Full Name | Neha Kumar |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Location | 833 S Governors Ave, Dover, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841420478 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | C10010583 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Neha Kumar, MD 833 S Governors Ave, Dover, DE 19904-4158 Ph: (800) 900-2020 | Neha Kumar, MD 833 S Governors Ave, Dover, DE 19904-4158 Ph: (800) 900-2020 |
News Archive
People with lower incomes are less likely to present at a hospital within 3 hours of stroke symptoms and thus have lower rates of thrombolysis therapy or post-stroke care than their more affluent counterparts, according to a retrospective analysis.
Fate Therapeutics, Inc. in collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the introduction of the first induced pluripotent stem cell (iPSC)-related product resulting from the collaboration between the two companies.
Rudolf Jaenisch of the Whitehead Institute of Biomedical Research in Cambridge, MA reports in the April 6, 2004 online issue of the Proceedings of the National Academy of Sciences that introduction of the MeCP2 protein into post-mitotic nerve cells of MeCP2 mutant mice rescues the symptoms of Rett Syndrome. This raises the possibility that neurons are functionally normal in a newborn child and that neural dysfunction manifests itself only later due to prolonged MeCP2 deficiency. If correct, therapeutic strategies aimed at preventing the onset of Rett symptoms could be initiated at birth.
Indiana University has been awarded $9.2 million from the National Science Foundation to lead two high-speed international network services. The awards provide IU with $4.6 million to continue the TransPAC3 network connection to Asia, and an additional $4.6 million for a new connection to Europe, named ACE - America Connects to Europe.
Mount Sinai scientists have identified two markers of inflammation that reliably predict the severity of COVID-19 cases and likelihood of survival, providing a foundation for a diagnostic platform and therapeutic targets, according to a study published in Nature Medicine in August.
› Verified 5 days ago
Dr. Andreas Rauer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 16 Old Rudnick Ln, Dover, DE 19901 Phone: 302-734-1760 Fax: 302-734-1720 | |
Gary I Markowitz, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 833 S Governors Ave, Dover, DE 19904 Phone: 302-674-1121 Fax: 302-674-3891 | |
Dr. David Michael Creech, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 130, Dover, DE 19904 Phone: 302-678-1700 Fax: 302-678-2330 | |
Dr. Timothy Francis-mooney Doyle, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 833 S Governors Ave, Dover, DE 19904 Phone: 302-674-1121 Fax: 302-674-3891 | |
Dr. Bryan D. Seiff, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 370, Dover, DE 19904 Phone: 302-678-3443 Fax: 302-678-9775 |